安領國際(01410.HK)斥300萬美元認購香港數字資產交易所優先股
安領國際(01410.HK)公布,於11月25日公司間接全資附屬作為認購人與各目標集團公司、目標公司的創辦人股東及其他A2系列優先股投資者訂立認購協議,認購人同意認購和目標公司同意按認購價300萬美元發行及配發A2系列優先股。
目標公司Tykhe Capital Group Limited於2018年7月成立,主要透過全資附屬公司香港數字資產交易所經營虛擬資產交易所。
香港數字資產交易所是首批就虛擬資產交易平台向證監會申請證券交易(第1類)及提供自動化交易服務(第7類)牌照的機構之一。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.